Emerging Therapies for Acne Vulgaris

@article{Trivedi2018EmergingTF,
  title={Emerging Therapies for Acne Vulgaris},
  author={Megha K Trivedi and Suzana S. Bosanac and Raja K. Sivamani and Larissa N Larsen},
  journal={American Journal of Clinical Dermatology},
  year={2018},
  volume={19},
  pages={505-516}
}
As we gain a greater understanding of acne pathogenesis, both new agents as well as new uses for established drugs are being considered for the treatment of acne vulgaris. Multiple clinical trials assessing new formulations or combinations of established acne treatments have been conducted, and novel uses of antimicrobials such as modified diallyl disulfide oxide and nitric oxide are being assessed in clinical trials. There are also a multitude of new therapies currently being studied that… 

Emerging drugs for the treatment of acne: a review of phase 2 & 3 trials

The review has dealt with anti-acne drugs undergoing phase II and III clinical trials with emphasis on the rationale of various combinations in tandem with the complex pathogenesis of the disease.

The immunomodulatory potential of phage therapy to treat acne: a review on bacterial lysis and immunomodulation

Phage therapy to treat acne can be a suitable therapeutic alternative to C. acnes control, which in turn can aid to restore the skin’s balance of microbiota.

Acne Vulgaris, Atopic Dermatitis and Rosacea: The Role of the Skin Microbiota—A Review

This review aims to investigate the current literature regarding the correlation between theSkin microbiota and its imbalance underlying microbiological aspects, how the skin microbiota changes over the course of the disease and the current possible treatments.

Treatment challenges in adult female acne and future directions

It is essential to value the negative impact on quality of life of adult female acne, independently of severity, and anti-acne drugs should be chosen in accordance with desire to be pregnant, presence of pregnancy or breastfeeding.

Antimicrobial peptides: a promising strategy for lung cancer drug discovery?

The combination of AMPs and other cancer treatment approaches such as chemotherapy, nanoparticle-based delivery systems, and photodynamic therapy can be used as a promising revolutionary strategy for the treatment of lung cancer.

Cutibacterium acnes Type II strains are associated with acne in Chinese patients

It is concluded that Type II strains are associated with acne in Chinese patients and discovered 90 unique genes of the six strains related to acne using pan-genome analysis.

Microbes as Drugs: The Potential of Pharmabiotics

The objective of this invited commentary is to increase health care provider awareness of pharmabiotics, living microbes, as a therapeutic modality that is poised to enter the market. As

Association of serum zinc and vitamin E levels with Acne vulgarisin Bangladeshi acne patients

A significant deficiency of serum vitamin E level in acne patients (p<0.001) was found, although the patients were not deficient in serum zinc level, which suggests that supplementation of vitamin E might be helpful in acne treatment.

Host Microbiota Balance in Teenagers with Gum Hypertrophy Concomitant with Acne Vulgaris: Role of Oral Hygiene Associated with Topical Probiotics

Both patients showed a significant clinical remission for gum hypertrophy and skin acne vulgaris during fixed orthodontic treatment with the administration of a formulate containing L. reuteri as a probiotic.

References

SHOWING 1-10 OF 76 REFERENCES

Emerging drugs for the treatment of acne

The relatively new combination therapy, adapalene-BP, limits antibiotic resistance and also helps simplify treatment regimens, and the newly developed topical nitric oxide-releasing agent also holds potential in limiting antibiotic resistance.

Botanical and Phytochemical Therapy of Acne: A Systematic Review

Clinical studies that have investigated the use of botanical agents in the treatment of acne vulgaris reported favorable results, and several showed equal or superior treatment to standard therapies, although further research is warranted.

Minocycline in Acne Vulgaris

  • F. Ochsendorf
  • Medicine
    American journal of clinical dermatology
  • 2010
Considering the aspects of efficacy, its adverse effect profile, resistance, price, and alternatives, minocycline is no longer considered the first-line antibacterial in the treatment of acne.

Zileuton, a new efficient and safe systemic anti-acne drug

Pre-treatment of SZ95 sebocytes with Zileuton partially prevented short-term arachidonic acid-induced effects, such as induction of LTB4 release, increase of neutral lipid content and stimulation of interlekin-6 release, while long-term treatment with Ziluton directly reduced the content of neutral lipids and interleukin- 6 release from SZ 95 sebocyte.

The Role of Photodynamic Therapy in Acne: An Evidence-Based Review

This review supports PDT as an efficacious treatment for acne and a good adjunctive treatment for mild to severe acne, especially in patients who have not responded to topical therapy and oral antibacterials, and are not great candidates for isotretinoin.

Epigallocatechin-3-gallate improves acne in humans by modulating intracellular molecular targets and inhibiting P. acnes.

EGCG significantly improved acne in an 8-week randomized, split-face, clinical trial, and was well tolerated, providing a therapeutic rationale for the use of EGCG in acne.

Resveratrol-Containing Gel for the Treatment of Acne Vulgaris

Positive results for resveratrol gel in acne are shown, and should be considered a valid starting point for further testing of the effectiveness of this molecule in different concentrations and formulations and in a larger group of patients.

Novel anti‐acne actions of nadifloxacin and clindamycin that inhibit the production of sebum, prostaglandin E2 and promatrix metalloproteinase‐2 in hamster sebocytes

Results provide novel evidence that NDFX and CLDM exhibit anti‐lipogenesis and anti‐inflammatory activities against insulin‐ or PGN‐activated sebocytes which at least partly mimic acne pathology in vitro.

Toll-like receptor 2 activation and comedogenesis: implications for the pathogenesis of acne

TLR activation and secretion of IL-1α from keratinocytes may be initiating steps in comedogenesis and, therefore, critical to the pathophysiology of acne.

Results of a Phase 2 Efficacy and Safety Study with SB204, an Investigational Topical Nitric Oxide-releasing Drug for the Treatment of Acne Vulgaris.

Both concentrations of topical SB204 were safe and well-tolerated and when compared to vehicle, both SB204 1% and SB204 4% significantly decreased the percentage of noninflammatory lesions and SB 204 4% also significantly decreasedThe percentage of inflammatory lesions in subjects with acne vulgaris treated for 12 weeks.
...